2018 JSH实践指南:血液恶性肿瘤—Ⅰ.白血病-4.慢性髓性白血病/骨髓增殖性肿瘤

2020-08-11 日本血液学会 Int J Hematol . 2020 Aug 11.

2018年日本血液学会(JSH)血液恶性肿瘤—急性髓性白血病的管理,本文为.慢性髓性白血病/骨髓增殖性肿瘤的管理指南。全文共针对12个临床问题提出指导建议。

中文标题:

2018 JSH实践指南:血液恶性肿瘤—Ⅰ.白血病-4.慢性髓性白血病/骨髓增殖性肿瘤

英文标题:

JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia‑4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN)

发布机构:

日本血液学会

发布日期:

2020-08-11

简要介绍:

2018年日本血液学会(JSH)血液恶性肿瘤—急性髓性白血病的管理,本文为.慢性髓性白血病/骨髓增殖性肿瘤的管理指南。全文共针对12个临床问题提出指导建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2018 JSH实践指南:血液恶性肿瘤—Ⅰ.白血病-4.慢性髓性白血病_骨髓增殖性肿瘤.pdf)] GetToolGuiderByIdResponse(projectId=1, id=025561c001955a41, title=2018 JSH实践指南:血液恶性肿瘤—Ⅰ.白血病-4.慢性髓性白血病/骨髓增殖性肿瘤, enTitle=JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia‑4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN), guiderFrom=Int J Hematol . 2020 Aug 11., authorId=0, author=, summary=2018年日本血液学会(JSH)血液恶性肿瘤&mdash;急性髓性白血病的管理,本文为.慢性髓性白血病/骨髓增殖性肿瘤的管理指南。全文共针对12个临床问题提出指导建议。, cover=https://img.medsci.cn/2020819/1597849571032_2020535.jpg, journalId=0, articlesId=null, associationId=1460, associationName=日本血液学会, associationIntro=, copyright=0, guiderPublishedTime=Tue Aug 11 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p><span style="color: #373737;">2018年日本血液学会(JSH)血液恶性肿瘤&mdash;急性髓性白血病的管理,本文为</span><span style="color: #373737;">.慢性髓性白血病/骨髓增殖性肿瘤的</span><span style="color: #373737;">管理指南。全文共针对12个临床问题提出指导建议。</span></p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=4900, tagName=慢性髓性白血病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4900, guiderKeyword=慢性髓性白血病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3425, appHits=183, showAppHits=0, pcHits=423, showPcHits=3242, likes=2, shares=13, comments=9, approvalStatus=1, publishedTime=Wed Aug 19 23:14:54 CST 2020, publishedTimeString=2020-08-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Aug 19 23:06:19 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 22:56:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2018 JSH实践指南:血液恶性肿瘤—Ⅰ.白血病-4.慢性髓性白血病_骨髓增殖性肿瘤.pdf)])
2018 JSH实践指南:血液恶性肿瘤—Ⅰ.白血病-4.慢性髓性白血病_骨髓增殖性肿瘤.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1002592, encodeId=c258100259259, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b65539669, createdName=ms4000000924855887, createdTime=Sun Jul 25 21:53:53 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923844, encodeId=bf3892384456, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a145394702, createdName=ms8000001286346667, createdTime=Tue Feb 09 08:54:17 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923781, encodeId=79fd923e8147, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Mon Feb 08 22:17:22 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901925, encodeId=03a2901925b7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:26:42 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901924, encodeId=6da89019249f, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:26:36 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2021-07-25 ms4000000924855887

    棒棒哒

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1002592, encodeId=c258100259259, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b65539669, createdName=ms4000000924855887, createdTime=Sun Jul 25 21:53:53 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923844, encodeId=bf3892384456, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a145394702, createdName=ms8000001286346667, createdTime=Tue Feb 09 08:54:17 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923781, encodeId=79fd923e8147, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Mon Feb 08 22:17:22 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901925, encodeId=03a2901925b7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:26:42 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901924, encodeId=6da89019249f, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:26:36 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2021-02-09 ms8000001286346667

    谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1002592, encodeId=c258100259259, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b65539669, createdName=ms4000000924855887, createdTime=Sun Jul 25 21:53:53 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923844, encodeId=bf3892384456, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a145394702, createdName=ms8000001286346667, createdTime=Tue Feb 09 08:54:17 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923781, encodeId=79fd923e8147, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Mon Feb 08 22:17:22 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901925, encodeId=03a2901925b7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:26:42 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901924, encodeId=6da89019249f, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:26:36 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2021-02-08 12314969m72暂无昵称

    太棒了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1002592, encodeId=c258100259259, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b65539669, createdName=ms4000000924855887, createdTime=Sun Jul 25 21:53:53 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923844, encodeId=bf3892384456, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a145394702, createdName=ms8000001286346667, createdTime=Tue Feb 09 08:54:17 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923781, encodeId=79fd923e8147, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Mon Feb 08 22:17:22 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901925, encodeId=03a2901925b7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:26:42 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901924, encodeId=6da89019249f, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:26:36 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2020-11-24 wxt0426

    很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1002592, encodeId=c258100259259, content=棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39b65539669, createdName=ms4000000924855887, createdTime=Sun Jul 25 21:53:53 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923844, encodeId=bf3892384456, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a145394702, createdName=ms8000001286346667, createdTime=Tue Feb 09 08:54:17 CST 2021, time=2021-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923781, encodeId=79fd923e8147, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72fa2381620, createdName=12314969m72暂无昵称, createdTime=Mon Feb 08 22:17:22 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901925, encodeId=03a2901925b7, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:26:42 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901924, encodeId=6da89019249f, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fc089965, createdName=wxt0426, createdTime=Tue Nov 24 20:26:36 CST 2020, time=2020-11-24, status=1, ipAttribution=)]
    2020-11-24 wxt0426

    谢谢

    0

拓展阅读

2016 中国慢性髓性白血病诊断与治疗指南

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2016-09-07

2020 ELN建议:慢性髓性白血病的治疗

欧洲白血病网(ELN,European LeukmiaNet) · 2020-03-03

慢性髓性白血病中国诊断与治疗指南(2020年版)

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2020-05-15

慢性髓性白血病诊疗指南 (2022年版)

中华人民共和国国家卫生健康委员会 · 2022-04-11

2023 国际儿童CML专家组建议:儿童和青少年慢性髓性白血病急变期的治疗

国际BFM研究组(I-BFM SG,International BFM Study Group) · 2023-01-27